Skip to main content
. 2016 Jul 12;7(5):588–598. doi: 10.1111/1759-7714.12374

Figure 4.

Figure 4

(a) Recurrence‐free survival of cancer patients with high (vesicular acetylcholine transporter [VAChT+] nerve score ≥ 3) and low (VAChT+ nerve score < 3) cholinergic nerve densities in tumor. P = 0.003 in all patients. (b) P < 0.001 in the patients who were not treated with postoperative adjuvant therapy. (c) P = 0.170 in patients treated with postoperative adjuvant therapy.